Physician profile
Seth Alan Hoffer
NPI 1104023142
$2,733.25
in general payments reported to CMS, 2019-2025
27 companies · $604 in 2025
The $604 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2020: $67.77 · 2021: $126 · 2022: $474 · 2023: $738 · 2024: $535 · 2025: $604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,876.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $563.57 | 2022-2023 | Modulus, Xlif, Reline |
| Globus Medical, INC. | $532.64 | 2024-2025 | Excelsius Gps, Reline, Signify |
| Stryker Corporation | $389.46 | 2019-2025 | Universal Neuro 3, Duramatrix, Adherus Autospray Dural Sealant |
| Medtronic, INC. | $335.05 | 2021-2025 | Mazor X System, Infinity Occipitocervical Upper Thoracic System, Stealthstation S8 Platform |
| Cumberland Pharmaceuticals, INC. | $150.65 | 2023-2024 | Caldolor, Vibativ |
| Ucb, INC. | $74.19 | 2024-2025 | Rystiggo, Zilbrysq, Briviact |
| Integra Lifesciences Corporation | $72.15 | 2023-2025 | Codman Certas, Cusa Clarity, Duraseal Exact Spinal Sealant System |
| Depuy Synthes Sales INC. | $57.36 | 2021 | |
| Zimmer Biomet Holdings, INC. | $55.77 | 2024-2025 | Neuro Plating System |
| Argenx US, INC. | $54.96 | 2022-2023 | Vyvgart |
| Providence Medical Technology, INC. | $48.06 | 2021 | |
| Aesculap, INC. | $36.99 | 2022-2025 | Craniofix Absorbable |
| Novartis Pharmaceuticals Corporation | $35.98 | 2019 | |
| Alnylam Pharmaceuticals INC. | $35.37 | 2025 | Onpattro |
| Ethicon US, LLC | $33.99 | 2025 | Surgiflo Hemostatic Matrix |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tanabe Pharma America, INC. | $31.15 | 2019-2023 | |
| Grifols USA, LLC | $30.38 | 2024 | Gamunex-C |
| Orthofix Medical, INC. | $29.66 | 2023-2025 | Spinal-Stim, Spinal-Stim |
| Alexion Pharmaceuticals, INC. | $25.74 | 2024 | Ultomiris |
| Amgen INC. | $24.48 | 2019 | |
| Theragen, INC. | $21.38 | 2024 | Actastim-S |
| Amylyx Pharmaceuticals, INC. | $19.30 | 2024 | Relyvrio |
| Biogen, INC. | $17.88 | 2024 | Qalsody, Spinraza |
| Astrazeneca Pharmaceuticals LP | $16.71 | 2024 | Wainua |
| Boston Scientific Corporation | $14.67 | 2023 | Superion Indirect Decompression System |
| Arteriocyte Medical Systems, INC. | $13.80 | 2020 | |
| Portola Pharmaceuticals, LLC | $11.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Hoffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.